Abstract:Study question: Is periconceptional multiple-micronutrient supplement (MMS) use including folic acid (FA) compared to FA use only associated with increased embryonic growth, development, and birth weight in a high-risk population? Summary answer: Women with MMS intake show no significant differences in first-trimester morphological embryo development, but increased first-trimester embryonic growth trajectories and fewer neonates born small for gestational age (SGA), less than the 3rd percentile (<p3), compared to women using only FA. What is known already: Periconceptional maternal FA intake in the general population is associated with increased embryonic and fetal growth, and reduced risks of neural tube defects, other congenital malformations, low birth weight, and neonates born SGA. Study design, size, duration: A prospective tertiary hospital-based cohort study (the Rotterdam Periconceptional Cohort) was conducted from January 2010 to December 2020. Participants/materials, setting, methods: We included 1076 women from the Rotterdam Periconceptional Cohort, before 10 weeks of pregnancy with follow-up until delivery. Embryonic growth was assessed by measurement of crown-rump length (CRL) and embryonic volume (EV), and embryonic morphology was described by Carnegie stages using longitudinal three-dimensional ultrasound scans and virtual reality techniques. Birth outcomes were extracted from medical records. General characteristics and supplement use were extracted from research questionnaires. Main results and the role of chance: This study showed increased embryonic growth trajectories (adjusted models, CRL: β = 0.052, 95% CI 0.012-0.090, EV: β = 0.022, 95% CI 0.002-0.042) in women using MMS compared to those using only FA. Moreover, a 45% reduced risk of a neonate-born SGA (<p3) was shown in women using MMS compared to FA users (adjusted OR = 0.546, 95% CI 0.308, 0.969). Embryonic morphological development (Carnegie stages) and the occurrence of miscarriages did not differ between women using MMS or solely FA. Limitations, reasons for caution: Following the heterogeneity of the composition and dose of MMS preparations, it is unclear which specific micronutrient, combination, or dose explains the increased embryonic growth trajectory and reduction in risk for SGA. This also hampers the possibility of differentiating between the effects of FA alone or as a component of MMS. Wider implications of the findings: Our findings emphasize the importance of periconceptional maternal MMS use as a potential preventative intervention against reduced embryonic growth and neonates born SGA. Therefore, we recommend the periconceptional use of MMS in women at risk of inadequate micronutrient intake. However, awareness of potentially harmful side effects of high doses and combinations of micronutrients is essential, therefore the optimal composition and dose need to be investigated, and careful surveillance is recommended. Study funding/competing interest(s): This research was funded by the Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands, and the ZonMw grant Open Competition 2018 (09120011910046). The authors declare that they have no conflict of interest. Trial registration number: NTR4356.

Association between dietary intake of creatine and female reproductive health: Evidence from NHANES 2017-2020

Dietary intake of creatine and risk of medical conditions in U.S. older men and women: Data from the 2017–2018 National Health and Nutrition Examination Survey

Creatine Supplementation in Women's Health: A Lifespan Perspective

Creatine and pregnancy outcomes: a prospective cohort study of creatine metabolism in low-risk pregnant females

Dietary creatine and cognitive function in U.S. adults aged 60 years and over

Assessing Dietary Creatine Intake in Population Studies: Challenges and Opportunities

Creatine Improves Total Sleep Duration Following Resistance Training Days versus Non-Resistance Training Days among Naturally Menstruating Females

Macronutrient and Micronutrient Intake Among US Women Aged 20 to 44 Years

Impact of Short-Term Creatine Supplementation on Muscular Performance among Breast Cancer Survivors

Effects of Creatine Supplementation on Endogenous Creatine Synthesis in Female and Male Rats in the Period of Growth and Development

The impact of creatine levels on musculoskeletal health in the elderly: a mendelian randomization analysis

The Association Between Daily Intake of Dietary Supplements and Self-Reported Endometriosis: A NHANES-Based Study

Effects of acute creatine supplementation on cardiac and vascular responses in older men; a randomized controlled trial

Exploring the relationship between creatine supplementation and renal function: insights from Mendelian randomization analysis

Disparities in Risks of Inadequate and Excessive Intake of Micronutrients during Pregnancy

Association between nutrient intake and female infertility: a study based on NHANES database

Establishing Reference Intakes for Creatine in Infants Aged 0 to 12 Months

Periconceptional maternal supplement intake and human embryonic growth, development, and birth outcomes: the Rotterdam Periconception Cohort

Creatine monohydrate use is prospectively associated with muscle dysmorphia symptomatology

The Association between Serum Creatinine/Cystatin C Ratio and Cardiovascular Morbidity and Mortality: Insights from NHANES

Effects of Creatine Supplementation and Resistance Training on Muscle Strength Gains in Adults < 50 Years of Age: A Systematic Review and Meta-Analysis